Traditional peptide drug discovery has been hindered by limited native peptide ligands and time-consuming optimization processes. Artificial intelligence (AI) and machine learning (ML) are reshaping peptide-based drug discovery by enabling rapid design, activity prediction, and optimization of novel therapeutics. This workshop will deep diving into the current AI/ML tools to design peptides, enabling optimization of their properties and high accuracy for downstream development.